Dr. Nicholas Clemons
Honorary
The Sir Peter MacCallum Department of Oncology
34 Scholarly works
5 Projects
HIGHLIGHTS
2020
Journal article
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death
DOI: 10.15252/emmm.2019108522020
Journal article
Clinical pathways and outcomes of patients with Barrett's esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008-2016.
DOI: 10.1093/dote/doaa1192020
Journal article
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma
DOI: 10.1002/path.55282020
Research Grant
ESTABLISHING THE FUNCTIONAL GENETIC DRIVERS OF OESOPHAGEAL ADENOCARCINOMA
2019
Journal article
Function of hTim8a in complex IV assembly in neuronal cells provides insight into pathomechanism underlying Mohr-Tranebjaerg syndrome
DOI: 10.7554/eLife.488282017
Research Grant
A NEW PARADIGM FOR TARGETING MUTANT P53 TUMOURS
2016
Research Grant
TARGETING MUTANT P53 IN OESOPHAGEAL CANCER
RECENT SCHOLARLY WORKS
2018
Journal article
Preclinical models for the study of Barrett's carcinogenesis
DOI: 10.1111/nyas.139162018
Journal article
TGF beta Signaling and Its Targeted Therapy in Gastrointestinal Cancers
2018
Journal article
Bridging the molecular divide: alcohol-induced downregulation of PAX9 and tumour development
DOI: 10.1002/path.50412017
Journal article
Inhibiting the system x((C)over-bar)/glutathione axis selectively targets cancers with mutant-p53 accumulation
DOI: 10.1038/ncomms148442017
Journal article
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
DOI: 10.1136/gutjnl-2015-3108882017
Journal article
Inhibiting system x(C)(-) and glutathione biosynthesis - a potential Achilles' heel in mutant-p53 cancers
DOI: 10.1080/23723556.2017.13447572016
Journal article
Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis
DOI: 10.18632/oncotarget.133912016
Journal article
Preclinical Models of Esophageal Adenocarcinoma for Drug Development